PULSE GEN MODEL 104
Report
- Report Number
- 1644487-2011-01057
- Event Type
- Malfunction
- Date Received
- May 20, 2011
- Date of Event
- November 21, 2007
- Report Date
- April 21, 2011
- Manufacturer
- CYBERONICS, INC.
- Product Code
- LYJ
- PMA / PMN Number
- P970003
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
ANALYSIS OF PROGRAMMING HISTORY.
IT WAS REPORTED THAT THE PHYSICIAN FELT THAT THE PT'S VNS GENERATOR "INTENSIFIED F/U INDICATOR (IFI)" HAD TRIPPED EARLIER THAN EXPECTED. BASED ON THE PT'S SETTINGS AND THE BATTERY LIFE ESTIMATION TABLES IN THE PHYSICIAN'S MANUAL, THE VNS GENERATOR IFI INDICATOR LIKELY SHOULD NOT HAVE TRIPPED. THE ALERT IS MEANT TO SERVE AS A NOTIFICATION TO THE TREATING PHYSICIAN THAT MORE FREQUENT CLINICAL MONITORING IS RECOMMENDED AS THE GENERATOR BATTERY WAS MEASURED TO BE AT A LEVEL WHERE MORE FREQUENT CLINICAL MONITORING IS RECOMMENDED. A REVIEW OF THE PREVIOUS PROGRAMMING HISTORY IDENTIFIED THAT THE VOLTAGE MEASURED BY THE GENERATOR LESS THAN ONE YEAR AFTER IMPLANT (2.756V) WAS UNCHARACTERISTICALLY LOW BASED ON PT THERAPY SETTINGS, SYSTEM IMPEDANCE AND IMPLANT DURATION. ADDITIONALLY, BASED ON THE TIMING OF THE INITIAL REPORT, IT APPEARS THAT THE MEASURED GENERATOR VOLTAGE HAS BEEN WITHIN THE IFI LIMITS (WHICH CORRESPONDS TO THE LAST 25% OF REMAINING BATTERY CAPACITY) FOR APPROX 2 YEARS, WHICH IS UNEXPECTED BEHAVIOR AT THESE VOLTAGES. A REVIEW OF THE GENERATOR'S DEVICE HISTORY RECORD (DHR) REVEALED THAT ALL ELECTRICAL TESTS/VISUAL INSPECTIONS WERE PASSED PRIOR TO DEVICE SHIPMENT AND THAT THE VOLTAGE MEASUREMENT ACCURACY OF THE GENERATOR WAS NEAR THE LOWER LIMIT OF THE SPEC, WHICH APPEARS TO EXPLAIN THE LOWER MEASURED VOLTAGE VALUE. ATTEMPTS FOR ADDITIONAL INFO ARE IN PROGRESS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PULSE GEN MODEL 104 | LYJ | CYBERONICS, INC. | 104 | 1952 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 56 YR | Female |